Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 2/20 | 0.43 |
| ▸ | MAOB | P27338 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
| ▸ | CFTR | P13569 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6568180 | 1.00 | ALDH1A1 (0.52) | ALDH1A1MAPK1LMNATDP1GAA | |
| SCHEMBL11868638 | 0.98 | ALDH1A1 (0.50) | ALDH1A1MAPK1LMNATDP1GAA | |
| SCHEMBL21309077 | 0.95 | ALDH1A1 (0.61) | ALDH1A1MAPK1LMNATDP1GAA | |
| SCHEMBL23279569 | 0.89 | ALDH1A1 (0.52) | ALDH1A1MAPK1LMNATDP1GAA | |
| SCHEMBL4258684 | 0.89 | CYP2A6 (0.50) | ALDH1A1MAPK1LMNATDP1CA2 | |
| SCHEMBL132983 | 0.87 | LMNA (0.60) | ALDH1A1LMNATDP1GAACA2 | |
| SCHEMBL5439069 | 0.87 | LMNA (0.60) | ALDH1A1LMNATDP1GAACA2 | |
| SCHEMBL5436616 | 0.87 | LMNA (0.60) | ALDH1A1LMNATDP1GAACA2 | |
| SCHEMBL14339307 | 0.84 | ALDH1A1 (0.50) | ALDH1A1MAPK1GAACA2MEN1 | |
| Triphenylphosphine Oxide SCHEMBL513223 | 0.84 | CA2 (0.58) | ALDH1A1LMNATDP1GAACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115135698-B | Process for producing cyclic polysiloxane | 信越化学工业株式会社 | 2024-04-26 | — | — | CN | claimed |
| CN-112266467-A | Polymer type phosphorus-nitrogen-containing flame retardant and preparation method thereof | 欧阳杰 | 2021-01-26 | — | — | CN | claimed |
| CN-112210131-A | Flame-retardant rubber and preparation method thereof | 马海社 | 2021-01-12 | — | — | CN | claimed |
| EP-4108706-B1 | METHOD FOR PRODUCING CYCLIC POLYSILOXANE | SHINETSU CHEMICAL CO (JP) | 2025-09-10 | — | — | EP | disclosed |
| CN-119968094-A | Hole transport composition, hole transport layer, preparation method of hole transport layer and perovskite battery | 天合光能股份有限公司 | 2025-05-09 | — | — | CN | disclosed |
| EP-3055891-B1 | SEMICONDUCTING MATERIAL COMPRISING A PHOSPHINE OXIDE MATRIX AND METAL SALT | NOVALED GMBH (DE) | 2024-10-30 | — | — | EP | disclosed |
| CN-113563379-B | Semiconductor material comprising a phosphine oxide matrix and a metal salt | 诺瓦尔德股份有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-115135698-B | Process for producing cyclic polysiloxane | 信越化学工业株式会社 | 2024-04-26 | — | — | CN | disclosed |
| EP-3281238-B1 | SEMICONDUCTING MATERIAL COMPRISING A PHOSPHINE OXIDE MATRIX AND METAL SALT | NOVALED GMBH (DE) | 2024-04-24 | — | — | EP | disclosed |
| EP-3259786-B1 | SEMICONDUCTING MATERIAL AND NAPHTOFURANE MATRIX COMPOUND FOR IT | NOVALED GMBH (DE) | 2023-08-30 | — | — | EP | disclosed |
| EP-3259786-B1 | SEMICONDUCTING MATERIAL AND NAPHTOFURANE MATRIX COMPOUND FOR IT | NOVALED GMBH (DE) | 2023-08-30 | — | — | EP | disclosed |
| US-20070238856-A1 | Trifluorovinyloxy monomers and polymers | GENERAL ELECTRIC COMPANY | 2007-10-11 | — | — | US | disclosed |
| US-20070080343-A1 | New materials for electroluminescence and the utilization thereof | MERCK PATENT GMBH (DE) | 2007-04-12 | — | — | US | disclosed |
| US-20070080343-A1 | New materials for electroluminescence and the utilization thereof | MERCK PATENT GMBH (DE) | 2007-04-12 | — | — | US | disclosed |
| US-20070080343-A1 | New materials for electroluminescence and the utilization thereof | MERCK PATENT GMBH (DE) | 2007-04-12 | — | — | US | disclosed |
| EP-1250341-B1 | A METHOD OF GENERATING A FUNCTIONALISED ARYLPHOSPHINE | UNIV LIVERPOOL (GB) | 2004-03-31 | — | — | EP | disclosed |
| US-20040059159-A2 | A Method of Generating A Functionalised Arylphosphine | THE UNIVERSITY OF LIVERPOOL (GB) | 2004-03-25 | — | — | US | disclosed |
| US-20030181767-A1 | Method of generating a functionalised arylphosphine | XIAO JIANLIANG (GB) | 2003-09-25 | — | — | US | disclosed |
| EP-1250341-A1 | A METHOD OF GENERATING A FUNCTIONALISED ARYLPHOSPHINE | THE UNIVERSITY OF LIVERPOOL (GB) | 2002-10-23 | — | — | EP | disclosed |
| WO-2001055156-A1 | A METHOD OF GENERATING A FUNCTIONALISED ARYLPHOSPHINE | THE UNIVERSITY OF LIVERPOOL (GB) | 2001-08-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030181767-A1 | Method of generating a functionalised arylphosphine | PHOSPHO1, PPIP5K2, PNPO | ALDH1A1 2565/4885MAPK1 924/4885LMNA 4290/4885 |
| US-20040059159-A2 | A Method of Generating A Functionalised Arylphosphine | PHOSPHO1, PFAS, PPIP5K2 | ALDH1A1 2971/4885MAPK1 1233/4885LMNA 3548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.